SARS-CoV-2 Spike S1 Antikörper (N-Term)
Kurzübersicht für SARS-CoV-2 Spike S1 Antikörper (N-Term) (ABIN7505826)
Target
Alle SARS-CoV-2 Spike S1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Goat anti-SARS-COV2 Spike protein- S1 Domain (N Terminal) Antibody
-
Sequenz
- PROPRIETAR Y
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 100-110 kDa band observed on recombinant SARS-COV2 Spike Protein S1. Recommended concentration 0.5-1 μg/mL. Primary incubation 1 hour at room temperature.
Peptide ELISA: antibody detection limit dilution 1:64000.
-
Kommentare
-
Immunofluorescence: Transient expression of SARS-CoV-2 spike protein expressing plasmid, seen in the cytoplasm of HEK293 transfected cells.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C. Minimize freezing and thawing.
-
-
- SARS-CoV-2 Spike S1
-
Hintergrund
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolate Wuhan-Hu-1
Target
-